Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis
โ Scribed by A. Smith; A. Weber; Rimmie Pandher; Judy Williams-Warren; M. L. Cohen; B. Ramsey
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 522 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Nitric oxide (NO) is produced by various cell types in the human respiratory tract. Endogenously produced nitric oxide is detectable in the exhaled air of healthy individuals. Exhaled NO has been shown to be increased in airway inflammation, most probably due to cytokine-mediated activation of NO sy
We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co
The majority of patients with cystic fibrosis (CF) will grow into adulthood. Despite this improvement in survival, the disease is progressive, especially with respect to the decline in pulmonary function, which in turn may have an impact on a patient's quality of life. In this study we evaluated the